PAT 20A/B Chapter Notes - Chapter N/A: Posttraumatic Stress Disorder, Urea Cycle, Benign Prostatic Hyperplasia

• School: Ryerson University
• Department: Pathotherapeutics
• Course: PAT 20A/B
• Professor: Audrey Kenmir

Document Summary

(2)pat20 winter week 5 drug classifications (mood disorders: anti-epileptic, valproate *central nervous system agent* (anti-seizure) Valproate drugs: divalproex sodium (depakote), valproic acid (depakene), valproate (depacon) Action: restores the balance of certain natural substances (neurotransmitters) in the brain. Uses: treats various types of seizure disorders, psychiatric conditions manic, prevents migraine headaches. Gi: mild nausea or vomiting, mild stomach pain, diarrhea, changes in appetite, weight gain. Cns: headache, mild dizziness, weakness, tremors; problems with balance or walking; Eent: blurred vision, double vision, ringing in the ears. Allergy to divalproex sodium, valproic acid or valproate sodium, live disease, urea cycle disorder, a genetic mitochondrial (mye-toe-kon-dree-al) disorder. Some products that may interact with this drug include: certain antidepressants (e. g. , amitriptyline), certain benzodiazepines (e. g. , diazepam), certain antibiotics (e. g. , carbapenems), mefloquine, other medications for seizure (e. g. , phenytoin), rifampin, warfarin, vorinostat, zidovudine. Assess: hypersensitivity, neurological status, gi status, signs and symptoms of pancreatitis.